Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ARIAD Pharmaceuticals Inc (NASDAQ:ARIA)

6.74
Delayed Data
As of Jun 27
 -0.44 / -6.13%
Today’s Change
4.37
Today|||52-Week Range
10.07
+7.84%
Year-to-Date

Today’s Trading

Previous close7.18
Today’s open7.10
Day’s range6.70 - 7.19
Volume4,625,188
Average volume (3 months)4,372,141
Market cap$1.4B
Dividend yield--
Data as of 06/27/2016

Growth & Valuation

Earnings growth (last year)-41.38%
Earnings growth (this year)+41.46%
Earnings growth (next 5 years)+41.39%
Revenue growth (last year)+12.70%
P/E ratioNM
Price/Sales9.93
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DBVTDBV Technologies SA+0.33+1.18%
LXRXLexicon Pharmaceutic...-0.51-3.74%
ABCOAdvisory Board Co-1.26-3.60%
NXTMNxStage Medical Inc+0.43+2.26%
Data as of 4:00pm ET, 06/27/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$118.8M
Annual profit (last year)-$231.2M
Net profit margin-194.57%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paris Panayiotopoulos
Chief Financial Officer, Treasurer &
Executive VP
Manmeet Singh Soni
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs